Corvus Pharmaceuticals Inc (CRVS)

Cost of Revenue

$55.00K

TTM · Period ending: · USD

CRVS logo

CRVS Cost of Revenue

Latest reported$55.00K
CRVS TTM Cost of Revenue ($0.00 → $55.00K)
High-resolution chart · PNG

CRVS cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Corvus Pharmaceuticals Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
55,000
55,000
26,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.